The global robotic surgical procedures market size was estimated to be USD 7.54 billion in 2023 and is expected to reach at USD 72.5 billion by 2033 with a CAGR of 22.85% during the forecast period 2023-2033. Increasing shortage of physicians & surgeons, growing adoption of automated instruments used for surgery, rising investments by major market players, surge in introduction of technologically advanced surgical robots, increasing prevalence of bone degenerative diseases, surge in number of hip & knee replacement surgeries, growing regulatory approvals for the robots used in surgery, rising number of robotic systems for surgical interventions, increasing research & development activities with respect to automated robotic systems, growing technological advancements in the field of automated medical instruments, and surge in collaborations within market players are the key factors propelling the market growth.
Surge in collaborations within market players is predicted to boost the market growth during the forecast period. For instance, In August 2022, THINK surgical, Inc., a leader in orthopedic surgical robots, revealed a collaboration with Curexo, Inc., a South Korea-based company specializing in medical robotics. The partnership involves a development and distribution agreement between the two companies.
By Product, Instruments & accessories was the highest revenue-grossing segment in the global robotic surgical procedures market in 2022 owing to the recurrent purchase of instruments & accessories, and growing technological advancements. Additionally, Laparoscopy robotic system is predicted to grow at fastest CAGR during the forecast period owing to the rising number of laparoscopic surgeries and growing approvals by regulatory bodies. For instance, in March 2021, The U.S. Food and Drug Administration (FDA) has granted marketing authorization for the Hominis Surgical System, a novel robotically-assisted surgical device (RASD) designed to assist in transvaginal hysterectomy for specific patients. This system is intended for performing benign hysterectomy (removal of the uterus for non-cancerous conditions) along with salpingo-oophorectomy (removal of one or both fallopian tubes and ovaries).
By Application, Others was the highest revenue-grossing segment in the global robotic surgical procedures market in 2022 owing to the increasing usage of robots for cancer treatment procedures and growing demand for minimally invasive laparoscopic surgeries. Additionally, Neurosurgery is predicted to grow at fastest CAGR during the forecast period owing to the growing adoption of robots in neurosurgeries, rising technical progress and great results from robotic neurosurgery, increasing usage of automated robotic instruments in brain surgeries, and surge in mergers & acquisitions between market players. For instance, in February 2021, Digital Surgery, a privately held surgical AI startup that specializes in digital education, data analytics, and training, has been acquired by Medtronic. This acquisition is part of Medtronic's strategy to enhance its robot-assisted surgical platform and expand its robotic system portfolio by introducing a new robot called Hugo.
By End-user, Hospitals & Clinics was the highest revenue-grossing segment in the global robotic surgical procedures market in 2022 owing to the surge in healthcare infrastructure, growing number of surgeries performed within hospitals, increasing prevalence of chronic diseases, growing demand for minimally invasive surgical procedures, increasing product approvals, and rising adoption of automated robotic surgical systems. For instance, in June 2022, Versius Surgical Robotic System has been used in 5,000 surgical operations worldwide, according to CMR Surgical (CMR). The milestone was achieved at Argenteuil Hospital in Paris, France, where Dr. Patrick Bagan and his team successfully performed a lung bi-segmentectomy for cancer treatment. Additionally, Ambulatory surgical centres is predicted to grow at fastest CAGR during the forecast period owing to the growing adoption of surgical procedures provided by ASCs at less expensive prices than hospitals, rising technological advancements, and surge in adoption of advanced automated technology.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing use of automated surgical equipment, surge in next-generation healthcare facilities, growing prevalence of chronic disorders such as cancer, diabetes, & cardiovascular diseases, rising adoption of automated surgical equipment, and increasing product approvals. For instance, in June 2022, Intuitive declared that the U.S. Food and Drug Administration has approved the integration of a mobile cone-beam CT (CBCT) imaging technology with the Ion Endoluminal System, which is utilized for robotic-assisted bronchoscopy. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising adoption of advanced automated surgical instruments, increasing awareness to adopt advanced medical technology, growing government initiatives for the development of advanced healthcare infrastructure, and surge in approvals by regulatory bodies. For instance, in August 2022, Brain Navi Biotechnology's neurosurgical navigation robot, NaoTrac, has received CE certification and approval from Taiwan's Food and Drug Administration (TFDA). By the end of 2022, the business plans to submit the device for FDA (Food and Drug Administration) clearance.
Surge in collaborations within market players is predicted to boost the market growth during the forecast period. For instance, In August 2022, THINK surgical, Inc., a leader in orthopedic surgical robots, revealed a collaboration with Curexo, Inc., a South Korea-based company specializing in medical robotics. The partnership involves a development and distribution agreement between the two companies.
By Product, Instruments & accessories was the highest revenue-grossing segment in the global robotic surgical procedures market in 2022 owing to the recurrent purchase of instruments & accessories, and growing technological advancements. Additionally, Laparoscopy robotic system is predicted to grow at fastest CAGR during the forecast period owing to the rising number of laparoscopic surgeries and growing approvals by regulatory bodies. For instance, in March 2021, The U.S. Food and Drug Administration (FDA) has granted marketing authorization for the Hominis Surgical System, a novel robotically-assisted surgical device (RASD) designed to assist in transvaginal hysterectomy for specific patients. This system is intended for performing benign hysterectomy (removal of the uterus for non-cancerous conditions) along with salpingo-oophorectomy (removal of one or both fallopian tubes and ovaries).
By Application, Others was the highest revenue-grossing segment in the global robotic surgical procedures market in 2022 owing to the increasing usage of robots for cancer treatment procedures and growing demand for minimally invasive laparoscopic surgeries. Additionally, Neurosurgery is predicted to grow at fastest CAGR during the forecast period owing to the growing adoption of robots in neurosurgeries, rising technical progress and great results from robotic neurosurgery, increasing usage of automated robotic instruments in brain surgeries, and surge in mergers & acquisitions between market players. For instance, in February 2021, Digital Surgery, a privately held surgical AI startup that specializes in digital education, data analytics, and training, has been acquired by Medtronic. This acquisition is part of Medtronic's strategy to enhance its robot-assisted surgical platform and expand its robotic system portfolio by introducing a new robot called Hugo.
By End-user, Hospitals & Clinics was the highest revenue-grossing segment in the global robotic surgical procedures market in 2022 owing to the surge in healthcare infrastructure, growing number of surgeries performed within hospitals, increasing prevalence of chronic diseases, growing demand for minimally invasive surgical procedures, increasing product approvals, and rising adoption of automated robotic surgical systems. For instance, in June 2022, Versius Surgical Robotic System has been used in 5,000 surgical operations worldwide, according to CMR Surgical (CMR). The milestone was achieved at Argenteuil Hospital in Paris, France, where Dr. Patrick Bagan and his team successfully performed a lung bi-segmentectomy for cancer treatment. Additionally, Ambulatory surgical centres is predicted to grow at fastest CAGR during the forecast period owing to the growing adoption of surgical procedures provided by ASCs at less expensive prices than hospitals, rising technological advancements, and surge in adoption of advanced automated technology.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing use of automated surgical equipment, surge in next-generation healthcare facilities, growing prevalence of chronic disorders such as cancer, diabetes, & cardiovascular diseases, rising adoption of automated surgical equipment, and increasing product approvals. For instance, in June 2022, Intuitive declared that the U.S. Food and Drug Administration has approved the integration of a mobile cone-beam CT (CBCT) imaging technology with the Ion Endoluminal System, which is utilized for robotic-assisted bronchoscopy. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising adoption of advanced automated surgical instruments, increasing awareness to adopt advanced medical technology, growing government initiatives for the development of advanced healthcare infrastructure, and surge in approvals by regulatory bodies. For instance, in August 2022, Brain Navi Biotechnology's neurosurgical navigation robot, NaoTrac, has received CE certification and approval from Taiwan's Food and Drug Administration (TFDA). By the end of 2022, the business plans to submit the device for FDA (Food and Drug Administration) clearance.
Segmentation: Robotic Surgical Procedures Market Report 2022 - 2033
Robotic Surgical Procedures Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Bn)
- Instruments & Accessories
- Services
Robotic Systems
- Laparoscopy Robotic System
- Neurosurgical Robotic Systems
- Orthopaedic Robotic System
- Others
Robotic Surgical Procedures Market Analysis & Forecast by Application 2022 - 2033 (Revenue USD Bn)
- Gynecology
- Urology
- Neurology
Orthopedics
- Spine
- Hip
- Knee
- Others
Others
- Oncology
- Laparoscopy
Robotic Surgical Procedures Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Ambulatory Surgical Centres
- Hospitals & Clinics
Robotic Surgical Procedures Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Robotic Surgical Procedures Market: Product Estimates & Trend Analysis
8. Robotic Surgical Procedures Market: Application Estimates & Trend Analysis
9. Robotic Surgical Procedures Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Robotic Surgical Procedures Market
12. Europe Global Robotic Surgical Procedures Market
13. Asia Pacific Global Robotic Surgical Procedures Market
14. Latin America Global Robotic Surgical Procedures Market
15. MEA Global Robotic Surgical Procedures Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- TransEnterix Surgical Inc.
- Smith & Nephew
- Medtronic
- Digital Surgery
- Stryker Corporation
- THINK Surgical Inc.
- Intuitive Surgical
- Renishaw plc
- Brain Navi Biotechnology
- Zimmer Biomet
- Medrobotics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 7.54 Billion |
| Forecasted Market Value ( USD | $ 72.5 Billion |
| Compound Annual Growth Rate | 22.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
